"Nothing is more important and personal than your health. At HSHS Sacred Heart Hospital, we invite you to experience a place where people are focused solely on helping you heal in body, mind and spirit; an environment where medicines most innovative technologies and teams come together to provide amazing treatments; a way of caring that embraces the sacredness of every human being. We are passionate about caring for you and your family."

During the past decade, HSHS Sacred Heart Hospital conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 52 clinical trials were completed, i.e. on average, 98.1% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 30 clinical trials were completed. i.e. 136.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HSHS Sacred Heart Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 59 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "Gynecologic Oncology Group" with 6 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HSHS Sacred Heart Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "HSHS Sacred Heart Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Clear Cell Renal Cell Carcinoma" (4 trials), "Invasive Breast Carcinoma" (4 trials) and "Recurrent Breast Carcinoma" (4 trials). Many other conditions were trialed in "HSHS Sacred Heart Hospital" in a lesser frequency.

Most popular intervention types in "HSHS Sacred Heart Hospital" are "Drug" (83 trials), "Other" (79 trials), "Biological" (47 trials), "Procedure" (23 trials) and "Radiation" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Quality-of-Life Assessment" (34 trials), "Paclitaxel" (14 trials), "Carboplatin" (13 trials) and "Cisplatin" (13 trials). Other intervention names were less common.

The vast majority of trials in "HSHS Sacred Heart Hospital" are 85 trials for "All" genders, 15 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "HSHS Sacred Heart Hospital". undefined are not yet recruiting, 20 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in HSHS Sacred Heart Hospital, 3 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in HSHS Sacred Heart Hospital, 1 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".